Fig. 3
hLRH1pS510-high is associated with poor prognosis in LUSC patients. The disease-free survival (A) and overall survival (B) for hLRH1pS510-high and hLRH1pS510-low in LUSC subjects are indicated
Fig. 3 | BMC Cancer
hLRH1pS510-high is associated with poor prognosis in LUSC patients. The disease-free survival (A) and overall survival (B) for hLRH1pS510-high and hLRH1pS510-low in LUSC subjects are indicated